Constellium (NYSE:CSTM) reported Q2 EPS of (EUR0.24), EUR0.66 worse than the analyst estimate of EUR0.42. Revenue for the quarter came in at EUR2.3 billion versus the consensus estimate of EUR2.05 billion.
Outlook:
Based on our current outlook, we expect Adjusted EBITDA in the range of €670 million to €690 million in 2022.